title: Effects of nimesulide on the small intestine mucositis induced by methotrexate in rats.
abstract: Intestinal mucositis is one of the major problems in the patients receiving cancer treatment. Nimesulide is a drug with antioxidant, antiinflammatory and antiulcer features. We aimed to investigate the effect of nimesulide on the small intestine mucositis induced by methotrexate (MTX) in rats. Experimental animals were divided into the control group, MTX group (MTXG) and nimesulide+MTX administered group (NMTXG) with eight rats per group. The control and MTXG groups were given distilled water by gavage and the NMTXG was given nimesulide 100 mg/kg orally. After one hour, the NMTXG and MTXG rat groups were administered oral MTX 5 mg/kg. This procedure was repeated once a day for 15 days and the rats were sacrificed. The duodenum and jejunum of each rat was removed for the assessment of biochemical markers and histopathological evaluation. Malondialdehyde (MDA) and myeloperoxidase (MPO) levels were significantly higher in the duodenal and jejunal tissues of the animals which received MTX, compared to the control and NMTXG (P<0.001). Also, the levels of total glutathione (tGSH), glutathione reductase (GSHRd), glutathione peroxidase (GSHPx), catalase (CAT) and superoxide dismutase (SOD) were significantly lower in the MTXG (P<0.001) compared to other groups. MTX led to villus and crypt epithelial damage and inflammation containing marked PMNL and eosinophils in the intestinal tissues histopathologically. Whereas, there was only mild irregularities in the villus structures of the NMTXG. Nimesulide protected the small intestines against damage by MTX. Intestinal mucositis caused by MTX may be preventable by co-administered nimesulide.
authors.affiliation: Department of Internal Medicine, Istinye State Hospital, 34465, Istanbul, Turkey.
authors.forename: Aynur
authors.initials: A
authors.lastname: Arslan
authors.forename: Adalet
authors.initials: A
authors.lastname: Ozcicek
authors.forename: Bahadir
authors.initials: B
authors.lastname: Suleyman
authors.forename: Taha Abdulkadir
authors.initials: TA
authors.lastname: Coban
authors.forename: Ferda Keskin
authors.initials: FK
authors.lastname: Cimen
authors.forename: Hatice Sevim
authors.initials: HS
authors.lastname: Nalkiran
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kuzucu
authors.forename: Durdu
authors.initials: D
authors.lastname: Altuner
authors.forename: Nihal
authors.initials: N
authors.lastname: Cetin
authors.forename: Halis
authors.initials: H
authors.lastname: Suleyman
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D004386:Duodenum / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D007583:Jejunum / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D052016:Mucositis / Q000139:chemically induced* / Q000188:drug therapy*; D051381:Rats; D017208:Rats, Wistar; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000964:Antimetabolites, Antineoplastic; D013449:Sulfonamides; C012655:nimesulide; D008727:Methotrexate